VP, Head of Biologics, Europe Mylan & Chair, Market Access Committee, Biosimilar Medicines Group, Medicines for Europe
Frankfurt am Main, Hessen, Germany
Global Director, Immunology (Biosimilars)
May 2015 to Present
Frankfurt Am Main Area, Germany
Patient Engagement Strategy Lead, XELJANZ RA Global Marketing & Commercial Development
January 2014 to April 2015
Marketing Platform Lead, XELJANZ - Emerging Markets
June 2013 to December 2013
Senior European Brand Manager, tofacitinib (CP 690,550)
December 2012 to June 2013
Rome Area, Italy
Senior European Brand Manager, Xiapex
January 2012 to December 2012
London, United Kingdom
European Brand Manager, Xiapex
November 2010 to January 2012
London, United Kingdom
Smiths Medical International
Global Product Manager, Tracheostomy
September 2009 to October 2010
Global Marketing Manager
November 2006 to June 2009
Greater Seattle Area
Karl Storz Endoscopy
Field Marketing Manager
March 2006 to September 2006
Marketing Communications Manager
August 2005 to February 2006
CH Mack, Inc.
Marketing Communications Consultant
March 2005 to August 2005
Sr. Marketing Specialist
September 2004 to March 2005
Premier Lease and Loan Services
December 2002 to September 2004
Lead a team to drive and implement pre-launch and mid/long range marketing strategy for the successful US and EU launch of a biosimilar asset within Immunology (RA, Psoriasis, IBD). Lead a team to drive and implement pre-launch and mid/long range marketing strategy for the successful US and EU launch of a biosimilar asset within Immunology (RA, Psoriasis, IBD).
What company does Erin Federman work for?
Erin Federman works for Boehringer Ingelheim
What is Erin Federman's role at Boehringer Ingelheim?
Erin Federman is Global Director, Immunology (Biosimilars)
What industry does Erin Federman work in?
Erin Federman works in the Pharmaceuticals industry.
Award-winning marketer with 15+ years of successes; launched 6 medical devices globally and 2 pharmaceutical assets (European/Global). Experience managing product portfolios of $100M+. Direct and indirect management experience. Broad geographic experience. Therapeutic Area/Indication experience: Cardiovascular, Tracheostomy/Airway, Imaging (ultrasound), Women's Health, Orthopedic/Hand Surgery, Rheumatology Skills: Global launch and in-market launch planning, market access strategies (including payer marketing, managed markets positioning), advocacy engagement, global commercial brand and strategic planning, market development, public/media relations including social media and e-marketing, forecasting, agency management, strategic portfolio planning, capacity planning, product life cycle management and planning, NPI, core asset development (branding and positioning), market surveillance, P&L management Written and spoken proficiency in French Strengths Finder: Input Command Strategic Learner Achiever Jungian type: Motivating DirectorGlobal Director, Immunology (Biosimilars) @ Lead a team to drive and implement pre-launch and mid/long range marketing strategy for the successful US and EU launch of a biosimilar asset within Immunology (RA, Psoriasis, IBD). From May 2015 to Present (7 months) Frankfurt Am Main Area, GermanyPatient Engagement Strategy Lead, XELJANZ RA Global Marketing & Commercial Development @ Work as a member of the XELJANZ RA Global Marketing and Commercial Development team responsible for developing and executing strategies to prepare for the worldwide launch, awareness and adoption of XELJANZ. Lead various strategic planning and product positioning initiatives for the brand including disease awareness, global PR/Advocacy strategies, market development, marketing plan development, budget oversight. Designated Launch Excellence and Strategy Expert by Pfizer Commercial Community. Led the development and execution of global RA NarRAtive patient education platform, involving 14 countries, over 3500 patients and over 1200 HCPs - including the selection and development of a global advisory panel consisting of 15 Rheumatologists and 13 Patient Advocacy Group representatives. From January 2014 to April 2015 (1 year 4 months) Marketing Platform Lead, XELJANZ - Emerging Markets @ Responsible for creating and directing a strategic marketing platform to drive the launch of a novel RA treatment across 73 countries in the Emerging Markets business unit. Geographic areas of focus include: Latin America, Eastern Europe, Russia, India, Turkey, Africa, Middle East, Asia and China. From June 2013 to December 2013 (7 months) Senior European Brand Manager, tofacitinib (CP 690,550) @ Responsible for developing and executing strategies to prepare for the launch, awareness and adoption of a novel treatment for RA across 16 countries in Europe, as well as leading strategic planning and product positioning initiatives for the brand. From December 2012 to June 2013 (7 months) Rome Area, ItalySenior European Brand Manager, Xiapex @ Responsible for driving the launch, awareness and adoption of the Xiapex brand across Europe, as well as leading strategic planning and product positioning initiatives for the brand. Led development and execution of award-winning "Dupuytren's Disease: It is in your hands" disease awareness platform. From January 2012 to December 2012 (1 year) London, United KingdomEuropean Brand Manager, Xiapex @ Responsible for driving the launch, awareness and adoption of the Xiapex (an innovative injectable treatment designed to treat Dupuytren's Contracture) brand into 16 major European markets. From November 2010 to January 2012 (1 year 3 months) London, United KingdomGlobal Product Manager, Tracheostomy @ Responsible for driving global success of £60M Tracheostomy franchise through effective long range planning, market development, identification of product opportunities and requirements, and successful roll out of new products to build the franchise. Ownership of global launch strategy development and implementation, including competitive advantage positioning, pricing, marketing material, training and education programmes definition. From September 2009 to October 2010 (1 year 2 months) Global Marketing Manager @ Responsible for strategic market development for four medical device market segments as well as leading the global launch of four new products, including line extensions. Areas of ownership include both upstream and downstream marketing initiatives, including product and competitive market analysis, pricing, market and product launches, messaging and positioning, campaign management and sales force tools. Proficient in developing both internal and external training materials. From November 2006 to June 2009 (2 years 8 months) Greater Seattle AreaField Marketing Manager @ Responsible for managing the professional relationship between Karl Storz and Ethicon Endo-Surgery in furtherance of all training, presentation and professional education initiatives relating to KSEA’s integrated digital operating room product suite (OR-1). From March 2006 to September 2006 (7 months) Cincinnati AreaMarketing Communications Manager @ Responsible for implementing and executing creative solutions to drive awareness, create demand and generate leads. Areas of focus included direct mail, advertising, e-marketing, DTC promotional materials and case studies. Accountable for marketing communications budget of over $700K. From August 2005 to February 2006 (7 months) Cincinnati AreaMarketing Communications Consultant @ Successfully revamped corporate branding, sales strategy, event management and public relations. Responsible for the development and management of Marketing Assistant. From March 2005 to August 2005 (6 months) Cincinnati AreaSr. Marketing Specialist @ Responsible for the marketing communications and design projects for the Consumer Lending Division of US Bank, the 6th largest bank in America. Fostered community relations and employee development initiatives. From September 2004 to March 2005 (7 months) Cincinnati AreaMarketing Specialist @ Supported marketing and event planning projects for a leading division of Great American Insurance Company specializing in B2B insurance products for the automotive and financial services industries. From December 2002 to September 2004 (1 year 10 months) Cincinnati AreaMBA, Marketing, International Business @ University of Cincinnati College of Business From 2002 to 2004 B.A., English Literature @ University of Cincinnati From 1994 to 1998 Erin Federman is skilled in: Product Launch, Product Marketing, Cross-functional Team Leadership, Marketing Strategy, Strategy, Competitive Analysis, Marketing Communications, Market Research, Strategic Planning, Integrated Marketing, Medical Devices, Marketing, Market Planning, Product Development, Global Marketing
Extraversion (E), Intuition (N), Feeling (F), Judging (J)
1 year(s), 0 month(s)
There's 73% chance that Erin Federman is seeking for new opportunities
Issued by Pharma Marketing Show · September 2012
Issued by SABRE Awards · -
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 400K users from
76% of Fortune 500 companies
The most accurate data ever
Hire Anyone, Anywhere
with ContactOut today
Making remote or global hires? We can help.
No credit card required